Manuscripts and Publications

Manuscript
[Anonymous].  0.  Abstract.
[Anonymous].  2018.  ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS INTERVENTIONS (ATN) DATA HARMONIZATION.
[Anonymous].  2018.  The association between incarceration and transactional sex among HIV-infected young men who have sex with men in the United States.
[Anonymous].  0.  Associations between cognitive performance and biomarkers of macrophage activation and inflammatory response among HIV-infected youth .
[Anonymous].  0.  Design and analysis considerations for a sequentially randomized HIV prevention trial.
[Anonymous].  0.  On Estimating Incidence from Cross-Sectional Data.
[Anonymous].  0.  Innovative Approaches to Minor Consent for Biomedical HIV Prevention Trials: Consent 2.0.
[Anonymous].  0.  Innovative Designs for Biobehavioral Research in Adolescent HIV.
[Anonymous].  2018.  Integrating PrEP into Family Planning Services at Title X Clinics in the Southeastern US – Phase 1 (ATN 155).
[Anonymous].  2018.  Research Priorities to End the Adolescent HIV Epidemic in the United States.
[Anonymous].  0.  Sexual Partner Characteristics, Relationship Type, and HIV Risk Among A Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex With Men.
[Anonymous].  2018.  Triggered Escalating Real-time Adherence Intervention to Promote Rapid HIV Viral Suppression among Youth Living with HIV Failing Antiretroviral Therapy: The TERA Study.
[Anonymous].  0.  Work2Prevent: Determining the essential components of an employment-focused HIV-prevention intervention for young men who have sex with men (YMSM) and transgender youth of color – Phase 1 (ATN 151).
[Anonymous].  0.  Work2Prevent: Employment as HIV prevention for young men who have sex with men (YMSM) and transgender youth of color – Phase 2 (ATN 151).
Publication
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, M Fernández I, Rutledge B, Martinez J, Garofalo R et al..  2013.  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.. J Acquir Immune Defic Syndr. 62(4):447-56.
Miller RLin, Reed SJ, Francisco V.  2013.  Accomplishing structural change: identifying intermediate indicators of success.. Am J Community Psychol. 51(1-2):232-42.
Nielsen-Saines K, Mitchell K, Kerin T, Fournier J, Kozina L, Andrews B, Cortado R, Bolan R, Flynn R, Rotheram MJane et al..  2019.  Acute HIV Infection in Youth: Protocol for the Adolescent Trials Network 147 (ATN147) Comprehensive Adolescent Research and Engagement Studies (CARES) Study.. JMIR Res Protoc. 8(1):e10807.
Belzer ME, MacDonell KKolmodin, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, Parsons JT.  2018.  Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART).. JMIR Res Protoc. 7(12):e11183.
Chutuape KS, Muyeed AZ, Willard N, Greenberg L, Ellen JM.  2014.  Adding to the HIV Prevention Portfolio - the Achievement of Structural Changes by 13 Connect to Protect Coalitions.. Glob J Community Psychol Pract. 5(2):1-8.
Bauermeister JA, Golinkoff JM, Muessig KE, Horvath KJ, Hightow-Weidman LB.  2017.  Addressing engagement in technology-based behavioural HIV interventions through paradata metrics.. Curr Opin HIV AIDS. 12(5):442-446.
Dietz E, Clum GA, Chung S-E, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM.  2010.  Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities.. J Adolesc Health. 46(3):278-83.
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD.  2015.  Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
Mullins TLKowalczy, Zimet G, Lally M, Kahn JA.  2016.  Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.. AIDS Patient Care STDS. 30(7):339-48.
Starks TJ, Ewing SWFeldstei, Lovejoy T, Gurung S, Cain D, Fan CA, Naar S, Parsons JT.  2019.  Adolescent Male Couples-Based HIV Testing Intervention (We Test): Protocol for a Type 1, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11186.
McCumber M, Cain D, LeGrand S, Mayer KH, Murphy DA, Psioda MA, Seña AC, Starks TJ, Hudgens M.  2018.  Adolescent Medicine Trials Network for HIV/AIDS Interventions Data Harmonization: Rationale and Development of Guidelines.. JMIR Res Protoc. 7(12):e11207.
Gilbert ALewis, Knopf AS, J Fortenberry D, Hosek SG, Kapogiannis BG, Zimet GD.  2015.  Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
Tanner AE, Philbin MM, Ma A, Chambers BD, Nichols S, Lee S, J Fortenberry D.  2017.  Adolescent to Adult HIV Health Care Transition From the Perspective of Adult Providers in the United States.. J Adolesc Health. 61(4):434-439.
Bryson YJ.  2018.  Advances, innovations, and challenges for new and old infections of children and adolescents.. Curr Opin Pediatr. 30(1):100-104.
Bruce D, Harper GW, M Fernández I, Jamil OB.  2012.  Age-concordant and age-discordant sexual behavior among gay and bisexual male adolescents.. Arch Sex Behav. 41(2):441-8.
Murphy DA, Chen X, Naar-King S, Parsons JT.  2012.  Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth.. AIDS Patient Care STDS. 26(2):95-100.
Bruce D, Kahana S, Harper GW, M Fernández I.  2013.  Alcohol use predicts sexual risk behavior with HIV-negative or partners of unknown status among young HIV-positive men who have sex with men.. AIDS Care. 25(5):559-65.
Gamarel KE, Nelson KM, Stephenson R, Rivera OJSantiago, Chiaramonte D, Miller RLin.  2018.  Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women.. AIDS Behav. 22(2):522-530.
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.  2013.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.. AIDS Res Hum Retroviruses. 29(3):493-500.
Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Howell K, Reid S et al..  2013.  An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.. JAMA Pediatr. 167(3):289-96.
Philbin MM, Kinnard EN, Tanner AE, Ware S, Chambers BD, Ma A, J Fortenberry D.  2018.  The Association between Incarceration and Transactional Sex among HIV-infected Young Men Who Have Sex with Men in the United States.. J Urban Health. 95(4):576-583.
Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L.  2019.  The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV.. J Int Assoc Provid AIDS Care. 18:2325958219867324.
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
Savel C, Mierzwa S, Gorbach PM, Souidi S, Lally M, Zimet G, Interventions A.  2016.  Avatar Web-Based Self-Report Survey System Technology for Public Health Research: Technical Outcome Results and Lessons Learned.. Online J Public Health Inform. 8(2):e189.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MIsabel, Rubin D.  2016.  Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care.. LGBT Health. 3(2):162-7.
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.  2015.  Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
Reed SJ, Miller RLin.  2014.  The Benefits of Youth Engagement in HIV-Preventive Structural Change Interventions.. Youth Soc. 46(4):529-547.
Willard N, Chutuape K, Stines S, Ellen JM.  2012.  Bridging the gap between individual-level risk for HIV and structural determinants: using root cause analysis in strategic planning.. J Prev Interv Community. 40(2):103-17.
Kahn JA, Xu J, Kapogiannis BG, Sleasman JW.  2017.  Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.. J Acquir Immune Defic Syndr. 75(2):241-245.
Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM.  2016.  Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.. J Acquir Immune Defic Syndr. 72(4):372-5.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2019.  Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.. J Acquir Immune Defic Syndr. 80(2):160-165.
Sill AM, Kreisel K, Deeds BGriffin, Wilson CM, Constantine NT, Peralta L.  2007.  Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.. J Clin Lab Anal. 21(1):40-5.

Pages